Lonza Strikes New Egypt Supply Deal

BASEL,, SwitzerlandLonza has signed a multi-year agreement to supply Carnipure tartrate and Carnipure crystalline to EVA Pharma, which has also signed a Carnipure® brand licensing agreement. This agreement extends an existing collaboration between both companies.

EVA Pharmas Carnivita Forte, an over-the-counter (OTC) product designed to promote fertility in men by increasing sperm count and sperm motility, is formulated with 1 g Carnipure tartrate per tablet. Thanks to Lonzas continuous support, we have been able to establish Carnivita Forte as one of our best-selling products in the field of urology, comments Dr. Riad Armanious, CEO of EVA Pharma.

Extensive research shows that Carnipure supplementation may positively influence sperm quality or, more specifically, sperm count, sperm motility and the number of motile sperm, thus playing an important part in male fertility, comments Ulla Freitas, Nutrition Science Team Leader at Lonza.